2008-07-02 19:59:17 -
www.companiesandmarkets.com adds new report - Martek Biosciences Corp - Premium Company Profile www.companiesandmarkets.com/Summary-Company-Profile/Martek-Biosc ..
Introduction
Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It´s research is focused on identifying and creating commercially viable products for the nutraceutical, pharmaceutical and functional foods markets.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial
trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Martek´s product focus is the development of nutritional products derived from microalgae, fungi and other microbes for the treatment of diseases in the area of inflammation, cognitive function and cardiovascular health. It has developed and patented two fermentable strains of microalgae which produce oils rich in docosahexaenoic acid (DHA).
A similar patented process was developed for a fungus that produces an oil rich in arachidonic acid, ARA. Both DHA and ARA are important nutrients for optimal infant development. It´s product folio includes Neuromins brand DHA supplements containing life´sDHA is a vegetarian source of docosahexaenoic acid, DHA for pregnant women.
Martek derives majority of its revenues from the product sales of infant formula that contains nutritional oils as well as from the product sales of Neuromins, a DHA dietary supplement. It also generates revenues through contract manufacturing for the production of enzymes, specialty chemicals, vitamins and agricultural specialty products.
Reasons to Purchase
Access all the important information and analysis on the company in a single report
Understand company´s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company´s adjusted five year financial data along with key ratios and market capitalization
